Cytohesin inhibitors – An innovative approach for the inhibition of EGFR signalling
Signalling of receptor tyrosine kinases such as EGFR is mediated by the extracellular binding of ligands triggering autophosphorylation. Until present this has been thought to be both necessary and sufficient for activating downstream signalling.
Surprisingly, cytoplasmic factors which regulate EGFR activation have been identified by the inventors. Inhibition of these so-called cytohesins decreased EGFR signalling whereas cytohesin overexpression stimulated receptor activation. With cytohesins thus being an interesting target for compounds treating cancer, the inventors have evaluated small molecules which exhibit a high selectivity for cytohesins as well as a low toxicity. They were able to demonstrate that the inhibition of cytohesins resulted in a reduced proliferation of EGFR-dependent lung cancer cells in vitro and in vivo. Furthermore, it was found that the substances exhibit a strong inhibition of glioblastoma cell proliferation. Additional data give reason to expect synergistic effects of a simultaneous treatment of cytohesin inhibitors and state of the art tyrosine kinase inhibitors.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…